
|Articles|January 15, 2005
Carl Zeiss, SOLA International merge in $1.1 billion deal
Aalen, Germany—A division of Carl Zeiss AG is combining with San Diego-based SOLA International in a $1.1 billion merger that will create one of the world's leading providers of ophthalmic lenses.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
2
FDA feedback supports Azura’s Ophthalmic's planned NDA for AZR-MD-001 in MGD
3
Alcon raises offer in amended deal to acquire STAAR Surgical
4
Improved grading scales for oncology drugs causing ocular adverse events
5













































.png)


